Search

everythinglearnresearchcommunity

for

Search:↓

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Two boys developed a viral skin infection during chemotherapy, which resolved with improved immune function.

Leukemia can sometimes appear as unusual skin issues in children.

The rash resolved after stopping ponatinib.

Etoposide is effective in treating several cancers, especially small cell lung cancer, with acceptable side effects.

Abnormal Hedgehog signaling in blood cancers may help tumors grow and resist chemotherapy, suggesting potential for targeted treatments.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

The conclusion is that different blood diseases cause specific oral symptoms and require varied treatments to manage these symptoms and improve patient health.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

Toxic epidermal necrolysis is a severe skin condition often caused by drugs, with complex treatment and a high risk of death, but survivors usually heal without scars.

Voriconazole can cause serious side effects, especially in long-term use.

Meis1 is crucial for skin health and tumor development.

AHCC reduces hair loss and liver injury caused by chemotherapy in rodents.

The effects of estrogen on human scalp hair growth are unclear and need more research.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Low doses of some substances can be beneficial, while high doses can be harmful or toxic.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Targeted cancer therapies often cause skin problems that need careful management to improve patient quality of life and treatment success.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Multimodal primary treatment improves survival in premenopausal breast cancer patients and is also beneficial for postmenopausal women.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Skin stem cells were turned into heart cells using a chemical, suggesting a new way to treat heart attacks.

The conclusion is that effective cancer treatment often requires a combination of therapies, but must be carefully managed due to serious side effects and the risk of immunosuppression.

Current treatments for hair loss from chemotherapy are limited, but new methods are being researched.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.